The UK Kidney Association (UKKA) has published a new report with 24 actionable recommendations to tackle AKI, a significant system-wide safety risk.
The report consolidates insights shared by over 120 multi-professional attendees at the National Acute Kidney Injury Summit held in Birmingham, in September 2023. It emphasises holistic management for high-risk populations, standardising AKI warning systems and recognising AKI as a marker of acute deterioration. It also highlights the importance of multi-professional teams, improved training and timely medication reinitiation for better patient outcomes. Endorsed by organisations such as the Royal College of Physicians, the Society for Acute Medicine and the British Geriatrics Society, this report serves as a vital tool for standardising care delivery. It also underscores the importance of post-discharge care pathways and hospital-wide AKI teams in reducing adverse outcomes and preventing readmissions. It is an essential resource for healthcare providers, commissioners, and policymakers seeking to improve AKI care and patient safety.
Read the full report and explore how it can help transform care in your setting: https://bit.ly/4g8nFcj
The UK NEQAS for Acute and Chronic Kidney Disease Scheme allows you to monitor both your AKI Algorithm and the impact of Creatinine measurement on AKI staging across all your analysers. For more information, please contact Birmingham Quality.